Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
Affordability is key to providing accessible healthcare for Bharat.
The combination will support clients in getting their end-to-end discovery and development programs delivered.
Acquisition positions Chiesi to expand patient access to approved treatments and advance efforts to develop new treatments for people living with rare diseases.
Clinical Decision Support Systems' huge potential to help ensure that each patient can receive high-quality care; study shows a reduction in diagnostic errors from 24% to 2%
The survey inspected ambulances operating throughout the city
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
India's strategy against Covid was more effective than any other countries in the world
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
CiRA, Kyoto University and Astellas - Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells
Subscribe To Our Newsletter & Stay Updated
